Smartleaf Asset Management’s Tourmaline Bio TRML Stock Holding History

Smartleaf Asset Management’s Portfolio TRML Stock Details TRML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-13	Closed	-$626	–	3554
2025 Q3	$626	Buy	+13	New	+$361	﹤0.01%	2821

Smartleaf Asset Management's TRML Position: Q4 2025 in Review

Smartleaf Asset Management sold out of Tourmaline Bio (TRML) in Q4 2025, closing a stake of 13 shares — an estimated $626 sold.

Smartleaf Asset Management first reported a position in TRML in Q3 2025 and held it in 1 quarter. The position peaked at $626 in Q3 2025. 0 funds tracked by Wall St. Rank hold TRML as of Q4 2025.

Smartleaf Asset Management reported no remaining Tourmaline Bio position as of Q4 2025 after selling out during the quarter.
Smartleaf Asset Management sold 13 Tourmaline Bio shares in Q4 2025, an estimated $626.
Smartleaf Asset Management first reported a position in Tourmaline Bio in Q3 2025 and held it in 1 quarter.
Smartleaf Asset Management's Tourmaline Bio position peaked at $626 in Q3 2025.
0 funds tracked by Wall St. Rank held Tourmaline Bio as of Q4 2025.

Based on Smartleaf Asset Management's 13F filing for Q4 2025, filed 13 Feb 2026.